Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
BBS7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
LINC00482 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
USP3-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC25A47 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF174 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VWA5B1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AVPR1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
POU2F2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WDR74 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CAND2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DERL3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
REV1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRR5L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MESP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TCF4-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on